Лучшие больницы для «Right Heart Catheterization» в Дубай, ОАЭ

The cost of a diagnostic Right Heart Catheterisation in paediatric patients ranges from approximately USD 1,500 to USD 4,500 in India, and from USD 3,500 to USD 9,000 in the UAE (Dubai or Abu Dhabi). India is typically 40–60% less expensive than the UAE for equivalent procedural and clinical standards. These ranges reflect a standard diagnostic RHC including catheterisation laboratory fees, paediatric cardiac anaesthesia, fluoroscopy and imaging, hospital stay of 1–3 days, standard post-procedure medications, and one cardiologist follow-up consultation. Combined procedures — such as simultaneous transcatheter device closure of an ASD or VSD, pulmonary artery stenting, or balloon septostomy — will increase costs and are quoted individually based on the specific intervention, device costs, and anticipated hospital stay. Both India and the UAE offer procedures at JCI-accredited and (in India) NABH-accredited hospitals, with internationally trained paediatric interventional cardiologists. GAF Healthcare provides a personalised cost estimate inclusive of all hospital, anaesthesia, and non-medical logistics costs following review of the child's medical records, allowing families to make a fully informed decision before travel.

For a straightforward diagnostic Right Heart Catheterisation without a concurrent interventional procedure, most children can be considered fit for short-haul international flights (under 4 hours) as early as 5–7 days after the procedure, provided vascular access sites are healing well, the child is haemodynamically stable, and there are no procedural complications. For long-haul international flights exceeding 4–6 hours, a minimum stay of 10–14 days in-country is recommended to allow adequate monitoring of haemodynamic stability, initiation and early tolerability assessment of any new PAH-targeted medications, and confirmation of normal access-site healing. Children who have undergone combined interventional procedures — such as transcatheter device closure, pulmonary artery stenting, or balloon septostomy — typically require 2–3 weeks in-country before long-haul flight clearance, as post-procedural surveillance echocardiography and antiplatelet or anticoagulation therapy monitoring are required. Children with established pulmonary arterial hypertension and resting oxygen saturations below 92% may require supplemental in-flight oxygen, which must be pre-arranged with the airline. GAF Healthcare coordinates formal fit-to-fly physician certification and assists families with airline medical clearance documentation prior to departure.

Right Heart Catheterisation achieves a diagnostic success rate of 95–98% in paediatric patients at high-volume centres, meaning that in the vast majority of cases the procedure provides the complete haemodynamic dataset required to guide clinical decision-making — including definitive pulmonary artery pressure quantification, accurate Qp:Qs shunt calculation, pulmonary vascular resistance indexing, and vasoreactivity classification. The overall major complication rate at accredited paediatric cardiac centres is below 1–2%, and procedure-related mortality in elective cases is exceptionally rare at less than 0.1%. The most commonly encountered complications are minor — including transient catheter-induced arrhythmias that resolve spontaneously, small access-site haematomas, and brief episodes of catheter-induced hypotension — all of which are managed immediately within the catheterisation laboratory. Serious but rare complications include significant vascular injury, cardiac tamponade from perforation, or haemodynamic deterioration during acute vasoreactivity testing, all of which are managed by experienced teams with PCICU and emergency surgical backup. The safety profile of this procedure has improved substantially over the past two decades due to ultrasound-guided vascular access, lower-profile paediatric catheter systems, advanced real-time imaging integration, and the concentration of complex cases in dedicated high-volume paediatric cardiac catheterisation programmes — which are precisely the centres that GAF Healthcare partners with in both India and the UAE.